Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 8, 2018

Primary Completion Date

September 10, 2019

Study Completion Date

October 10, 2019

Conditions
Coronary Artery DiseaseDiabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin 50 mg Oral Tablet

Patients who the endocrinologist prescribed them Vildagliptin 50 mg Oral Tablet plus their Metformin 1000 mg Oral Tablet to control their blood sugar level.

DRUG

Metformin 1000 mg Oral Tablet

Patients with Coronary artery diseases.and uncontrolled Diabetes Mellitus type 2 who's taking Metformin 1000 mg Oral Tablet only will be enrolled from endocrinology clinic.

DRUG

Glimepiride upto 4 mg Oral Tablet

Patients who the endocrinologist prescribed them Glimepiride 4 mg oral tablet plus their Metformin 1000 mg Oral Tablet

Trial Locations (1)

Unknown

Faculty of Pharmacy - Damanhour University., Damanhūr

All Listed Sponsors
collaborator

Tanta University

OTHER

lead

Damanhour University

OTHER

NCT03693560 - Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD | Biotech Hunter | Biotech Hunter